The in vitro diagnostics industry has been at the forefront of the fight against SARS-CoV-2. Here, Mark Reed provides a commercial perspective and overview of the unprecedented times experienced over the past 12 months.
Looking back at 2020, I am quite sure that there isn’t a diagnostic manufacturing or distribution company in the UK, or even the world, that hasn’t been affected in some way by the SARS-CoV-2 pandemic, be that professionally or personally.
As coronavirus continues to spread, and mutate, so testing methods have developed to detect the virus more effectively. Testing has always been integral to diagnosis, understanding its spread, and taking preventive measures to protect populations. The more rapid and reliable the test, the quicker there can be a diagnosis.
A brief timeline review
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Register
